CELIA FERNANDEZ: Open Payments
NPI 1447313952 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,997 in 103 payments from 16 companies in 2025. Trend: 2023 $2,653 · 2024 $2,374 · 2025 $1,997
Food & beverage: $1,997
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $660 |
| Amgen Inc. | 21 | $221 |
| UCB, Inc. | 6 | $215 |
| Indivior Inc. | 7 | $165 |
| Janssen Biotech, Inc. | 9 | $154 |
| Novartis Pharmaceuticals Corporation | 7 | $138 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| GENZYME CORPORATION | 3 | $69 |
| ANI Pharmaceuticals, Inc. | 2 | $65 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
Products named: RINVOQ, Bimzelx, SUBLOCADE, TREMFYA, KRYSTEXXA, COSENTYX, SKYRIZI, BENLYSTA.
Industry payments across AL — which companies pay providers there.
